A disruptive technology to tackle brain cancer and glioblastoma
News
Hemerion and Mount Sinai Health System nominated for the Galien MedStartup Awards 2021
Hemerion and its clinical partner Mount Sinai Health System have been nominated for the 8th edition of the Galien MedStartUp Awards, the innovation prize created by the Galien Foundation and… ...
Hemerion technology to be further evaluated in the DOSINDYGO multi-center clinical trial
The Hemerion technology, which associates drugs and photonic treatments against glioblastoma, is to be evaluated in the DOSINDYGO clinical trial.This new clinical trial is sponsored by CHU de Lille (PI… ...
The Hemerion technology presented at the Miami Global Brain Tumor Symposium
Pr. Nicolas Reyns, Head of the neurosurgery oncology dept. of the University Hospital of Lille, has been developing photodynamic therapy since 2010 in partnership with the Inserm laboratory U1189 OncoThAI.… ...